Search Within

Charlotte Eielson Ariyan

  1. "Katherine Panageas"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (11)
  3. Miscellaneous (1)
Groups
  1. Biostatistics Service (26)
  2. Epidemiology and Biostatistics (26)
  3. Melanoma Disease Management Team (26)
  4. Population Sciences Research Program (26)
  5. Surgery (26)
  6. Survivorship Research (23)

More Groups

People
  1. Katherine Panageas (26)
  2. Daniel Coit (23)
  3. Mary Brady (21)
  4. Jedd Wolchok (11)
  5. Michael Postow (11)
  6. Danielle Bello (8)

More People

Years
  1. 2021 (3)
  2. 2020 (3)
  3. 2018 (3)
  4. 2017 (4)
  5. 2016 (3)
  6. 2015 (1)

More Years

Publications
  1. Annals of Surgical Oncology (16)
  2. Journal of Clinical Oncology (3)
  3. Cancer (1)
  4. Cancer Discovery (1)
  5. Cancer Immunology Research (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. Springer (16)
  2. American Association for Cancer Research (3)
  3. American Society of Clinical Oncology (3)
  4. Elsevier Inc. (1)
  5. Impact Journals (1)
  6. Oxford University Press (1)

More Publishers

Results (26)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • ASO Visual Abstract: Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma
    Miscellaneous

    Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Assessment of frailty can guide decision making for utilization of sentinel lymph node biopsy in patients with thick melanoma
    Journal Article

    Sharma, A. S.; Flynn, J. R.; Panageas, K. S.; Shahrokni, A.; Tin, A. L.; Bello, D. M.; Ariyan, C. E.; Brady, M. S.; Coit, D. G.; Bartlett, E. K.
    Annals of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Therapeutic implications of detecting MAPK-activating alterations in cutaneous and unknown primary melanomas
    Journal Article

    Shoushtari, A. N.; Chatila, W. K.; Arora, A.; Sanchez-Vega, F.; Kantheti, H. S.; Rojas Zamalloa, J. A.; Krieger, P.; Callahan, M. K.; Betof Warner, A.; Postow, M. A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Response to checkpoint blockade and survival in patients with stage III melanoma
    Meeting Abstract

    Theriot, J.; Bello, D.; Lobaugh, S.; Bartlett, E. K.; Betof, A.; Shoushtari, A.; Postow, M.; Callahan, M.; Brady, M. S.; Wong, R.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • Survival outcomes after metastasectomy in melanoma patients categorized by response to checkpoint blockade
    Journal Article

    Bello, D. M.; Panageas, K. S.; Hollmann, T.; Shoushtari, A. N.; Momtaz, P.; Chapman, P. B.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; more...
    Annals of Surgical Oncology (2020)

    Fulltext@MSK | Save
  • High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy
    Journal Article

    Bartlett, E. K.; Flynn, J. R.; Panageas, K. S.; Ferraro, R. A.; Sta.Cruz, J. M.; Postow, M. A.; Coit, D. G.; Ariyan, C. E.
    Cancer (2020)

    Fulltext@MSK | Save
  • Adipocyte-derived lipids mediate melanoma progression via FATP proteins
    Journal Article

    Zhang, M.; Di Martino, J. S.; Bowman, R. L.; Campbell, N. R.; Baksh, S. C.; Simon-Vermot, T.; Kim, I. S.; Haldeman, P.; Mondal, C.; Yong-Gonzales, V.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Outcomes of patients with metastatic melanoma selected for surgery after immunotherapy
    Meeting Abstract

    Bello, D. M.; Panageas, K. S.; Hollmann, T. J.; Shoushtari, A. N.; Chapman, P.; Postow, M. A.; Callahan, M. K.; Wolchok, J. D.; Brady, M. S.; Coit, D.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Four-month course of adjuvant dabrafenib in patients with surgically resected stage IIIC melanoma characterized by a BRAFV600E/K mutation
    Journal Article

    Momtaz, P.; Harding, J. J.; Ariyan, C.; Coit, D. G.; Merghoub, T.; Gasmi, B.; You, D.; Viale, A.; Panageas, K. S.; Samoila, A.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save